Categories: Health

Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference

PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.

About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com 

GlobeNews Wire

Recent Posts

Chandigarh University researchers use Artificial Intelligence to develop Model for predicting Accurate Crop Yield; Innovation to benefit Indian Farmers

Researchers have leveraged Climate Data and Satellite Technology for developing the predictive modelCHANDIGARH, India, June…

53 minutes ago

Clean Energy Chain Section at the 4th CISCE Highlights Low-Carbon Innovation Across the Energy Value Chain

BEIJING, June 26, 2026 /PRNewswire/ -- The Clean Energy Chain section of the fourth China…

53 minutes ago

Advanced Manufacturing Chain Section at CISCE Highlights Low-Altitude Economy, Aviation Value Chain and New Materials Innovations

BEIJING, June 26, 2026 /PRNewswire/ -- With the theme of "Making Production More Efficient," the…

53 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use…

54 minutes ago

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

LIKMEZ® (ATI-1501) commercial momentum building in U.S. marketUS$40 million NIAID award supporting VXV-01 advancement through…

7 hours ago

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

BEDMINSTER, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE…

7 hours ago